INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "NOVEL NUCLEOTIDES AND OLIGONUCLEOTIDES AND RNAI AGENTS COMPRISING THE SAME"

GENEVA, Sept. 17 -- ELI LILLY AND COMPANY (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2025/018071) for "NOVEL NUCLEOTIDES AND OLIGONUCLEOTIDES AND RNAi AGENTS COMPRISING THE SAME" on Mar 03, 2025. With publication no. WO/2025/188589, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BAWEL, Seth Andrew (c/o Eli Lilly and CompanyP.O. Box 6288Indianapolis, Indiana 46206-6288), JESSOP, Theodore Curtis (c/o Eli Lilly and CompanyP.O. Box 6288Indianapolis, Indiana 46206-6288)

Abstract: ...